These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 26808778)

  • 1. Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program.
    Doi AM; Pignatari AC; Edmond MB; Marra AR; Camargo LF; Siqueira RA; da Mota VP; Colombo AL
    PLoS One; 2016; 11(1):e0146909. PubMed ID: 26808778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009.
    Pfaller MA; Moet GJ; Messer SA; Jones RN; Castanheira M
    Antimicrob Agents Chemother; 2011 Feb; 55(2):561-6. PubMed ID: 21115790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
    Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
    Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.
    Taj-Aldeen SJ; Kolecka A; Boesten R; Alolaqi A; Almaslamani M; Chandra P; Meis JF; Boekhout T
    Infection; 2014 Apr; 42(2):393-404. PubMed ID: 24352810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016.
    Toda M; Williams SR; Berkow EL; Farley MM; Harrison LH; Bonner L; Marceaux KM; Hollick R; Zhang AY; Schaffner W; Lockhart SR; Jackson BR; Vallabhaneni S
    MMWR Surveill Summ; 2019 Sep; 68(8):1-15. PubMed ID: 31557145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and prognostic factors of nosocomial candidemia in Northeast Brazil: A six-year retrospective study.
    Medeiros MAP; Melo APV; Bento AO; Souza LBFC; Neto FAB; Garcia JB; Zuza-Alves DL; Francisco EC; Melo ASA; Chaves GM
    PLoS One; 2019; 14(8):e0221033. PubMed ID: 31437188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
    Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
    Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil.
    Canela HMS; Cardoso B; Vitali LH; Coelho HC; Martinez R; Ferreira MEDS
    Mycoses; 2018 Jan; 61(1):11-21. PubMed ID: 28940753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
    Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
    PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures.
    Megri Y; Arastehfar A; Boekhout T; Daneshnia F; Hörtnagl C; Sartori B; Hafez A; Pan W; Lass-Flörl C; Hamrioui B
    Antimicrob Resist Infect Control; 2020 Apr; 9(1):50. PubMed ID: 32264966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing epidemiology of candidemia in a medical center in middle Taiwan.
    Hii IM; Chang HL; Lin LC; Lee YL; Liu YM; Liu CE; Chen CH; Cheng YR; Chang CY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):306-15. PubMed ID: 24113067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial bloodstream Candida infections in a tertiary-care hospital in South Brazil: a 4-year survey.
    da Costa VG; Quesada RM; Abe AT; Furlaneto-Maia L; Furlaneto MC
    Mycopathologia; 2014 Oct; 178(3-4):243-50. PubMed ID: 25103140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil.
    Aquino VR; Lunardi LW; Goldani LZ; Barth AL
    Braz J Infect Dis; 2005 Oct; 9(5):411-8. PubMed ID: 16410893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
    Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
    Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution, trends, and antifungal susceptibility of Candida species causing candidemia in Japan, 2010-2019: A retrospective observational study based on national surveillance data.
    Kajihara T; Yahara K; Nagi M; Kitamura N; Hirabayashi A; Hosaka Y; Abe M; Miyazaki Y; Sugai M
    Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36095139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of therapeutic strategies on the prognosis of candidemia in the ICU.
    Puig-Asensio M; Pemán J; Zaragoza R; Garnacho-Montero J; Martín-Mazuelos E; Cuenca-Estrella M; Almirante B; ; ; ;
    Crit Care Med; 2014 Jun; 42(6):1423-32. PubMed ID: 24557426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.
    Chen YC; Kuo SF; Chen FJ; Lee CH
    Mycoses; 2017 Feb; 60(2):89-95. PubMed ID: 27621210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
    Iatta R; Caggiano G; Cuna T; Montagna MT
    J Chemother; 2011 Apr; 23(2):92-6. PubMed ID: 21571625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.